These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension. Pepke-Zaba J; Jais X; Channick R Ann Am Thorac Soc; 2016 Jul; 13 Suppl 3():S248-54. PubMed ID: 27571006 [TBL] [Abstract][Full Text] [Related]
3. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension. Zhang Y; Yu X; Jin Q; Luo Q; Zhao Z; Zhao Q; Yan L; Liu Z Heart Fail Rev; 2019 Nov; 24(6):949-965. PubMed ID: 31044326 [TBL] [Abstract][Full Text] [Related]
4. Chronic thromboembolic pulmonary hypertension: role of medical therapy. Pepke-Zaba J; Jansa P; Kim NH; Naeije R; Simonneau G Eur Respir J; 2013 Apr; 41(4):985-90. PubMed ID: 23397304 [TBL] [Abstract][Full Text] [Related]
6. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension. Garnock-Jones KP Drugs; 2014 Nov; 74(17):2065-78. PubMed ID: 25352393 [TBL] [Abstract][Full Text] [Related]
7. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ; J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129 [TBL] [Abstract][Full Text] [Related]
8. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Pepke-Zaba J; Delcroix M; Lang I; Mayer E; Jansa P; Ambroz D; Treacy C; D'Armini AM; Morsolini M; Snijder R; Bresser P; Torbicki A; Kristensen B; Lewczuk J; Simkova I; Barberà JA; de Perrot M; Hoeper MM; Gaine S; Speich R; Gomez-Sanchez MA; Kovacs G; Hamid AM; Jaïs X; Simonneau G Circulation; 2011 Nov; 124(18):1973-81. PubMed ID: 21969018 [TBL] [Abstract][Full Text] [Related]
10. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm. Bresser P; Pepke-Zaba J; Jaïs X; Humbert M; Hoeper MM Proc Am Thorac Soc; 2006 Sep; 3(7):594-600. PubMed ID: 16963540 [TBL] [Abstract][Full Text] [Related]
11. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension. Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S Respiration; 2018; 96(2):127-137. PubMed ID: 29642071 [TBL] [Abstract][Full Text] [Related]
12. [The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat]. Gratsianskaya SE; Valieva ZS; Martynyuk TV Ter Arkh; 2020 Oct; 92(9):77-84. PubMed ID: 33346435 [TBL] [Abstract][Full Text] [Related]
13. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry]. Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary Hypertension: A Brief Guide for Clinicians. Mandras SA; Mehta HS; Vaidya A Mayo Clin Proc; 2020 Sep; 95(9):1978-1988. PubMed ID: 32861339 [TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension: an endothelin receptor antagonist improves the peak PETCO2. Hirashiki A; Adachi S; Nakano Y; Kono Y; Shimazu S; Shimizu S; Morimoto R; Okumura T; Takeshita K; Yamada S; Murohara T; Kondo T Life Sci; 2014 Nov; 118(2):397-403. PubMed ID: 24641953 [TBL] [Abstract][Full Text] [Related]
16. Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension. Ghofrani HA; D'Armini AM; Kim NH; Mayer E; Simonneau G Respir Med; 2021 Feb; 177():106293. PubMed ID: 33465538 [TBL] [Abstract][Full Text] [Related]
17. Bosentan for chronic thromboembolic pulmonary hypertension. Confalonieri M; Kodric M; Longo C; Vassallo FG Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311 [TBL] [Abstract][Full Text] [Related]